Monitoring of Brain Metabolites Using Proton and Deuterium MR Techniques

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 140 participants.

Also called NCT06705010

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; single masking; primary purpose basic science
Phase
Not applicable
Enrolled
  • 140 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06705010
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Switzerland (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06705010. Non-randomized; single masking; primary purpose basic science. Start 2025-04-01 (anticipated); primary completion 2026-11-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Monitoring of Brain Metabolites Using Proton and Deuterium MR Techniques
Acronym
SIGNATURES2023
Condition
Aging
Condition
Brain Metabolic Disorder
Condition
Carotid Stenosis
Condition
Alzheimer Disease
Condition
Diabetes Type 2
Condition
Mild Cognitive Impairment
Condition
Brain Disease
Intervention (Device)
Application of new pulse sequence package SIGNATURES2023 to healthy controls
Intervention (Device)
Application of new pulse sequence package SIGNATURES2023 to 4 groups of patients (pilot)
Lead sponsor
Insel Gruppe AG, University Hospital Bern (class: other)

Record details

Record id
cardio:ct-nct06705010
Content hash
06fb1d32626d5d4d2cad3e97dce3f42a706b755f30d3672771687c1635e9986d